Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data

被引:97
作者
Broman, Aimee Teo [1 ,2 ]
Quigley, Harry A. [1 ,2 ]
West, Sheila K. [1 ,2 ,3 ]
Katz, Joanne [1 ,2 ,3 ]
Munoz, Beatriz [1 ,2 ]
Bandeen-Roche, Karen [3 ]
Tielsch, James M. [1 ,2 ,3 ]
Friedman, David S. [1 ,2 ,3 ]
Crowston, Jonathan [4 ]
Taylor, Hugh R. [4 ]
Varma, Rohit [5 ,6 ]
Leske, M. Cristina [7 ,8 ]
Bengtsson, Boel [9 ]
Heijl, Anders [9 ]
He, Mingguang [10 ,11 ]
Foster, Paul J. [10 ,12 ]
机构
[1] Johns Hopkins Univ Hosp, Glaucoma Serv, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia
[5] Univ So Calif, Kech Sch Med, Dept Prevent Med, Los Angeles, CA USA
[6] Univ So Calif, Kech Sch Med, Dept Ophthalmol, Los Angeles, CA USA
[7] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA
[8] SUNY Stony Brook, Dept Ophthalmol, Stony Brook, NY 11794 USA
[9] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Div Ophthalmol, S-22100 Lund, Sweden
[10] UCL, Inst Ophthalmol, London, England
[11] Sun Yat Sen Univ, Minist Educ, Zhongshan Ophthalmol Ctr, Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China
[12] Moorfields Eye Hosp, Glaucoma Res Unit, London, England
关键词
D O I
10.1167/iovs.07-0866
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To estimate the rate of visual field progression in open-angle glaucoma (OAG) subjects, by using data from population-based cross-sectional studies. METHODS. Subjects with OAG were identified in nine surveys of randomly sampled populations using standard criteria for glaucomatous optic neuropathy. Subjects were of European, African, Chinese, and Hispanic ethnicity. The measure of OAG damage was the mean deviation (MD) of an automated visual field test (Humphrey Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA). The rate of progression was the mean of all subjects' damage in the worse eye divided by an average time since onset. Time since onset was estimated from age-specific prevalence rates. RESULTS. A total of 1066 subjects with OAG contributed visual field data. The mean worsening in decibels per year was: European-derived, -1.12; Hispanic, -1.26; African-derived, -1.33; and Chinese -1.56 (difference among ethnicities, P = 0.16). The mean duration of disease was lowest among Chinese persons at 10.5 years (95% CI: 8.8-12.6) and was highest in African-derived subjects at 15.4 years (95% CI: 14.6-15.9). The progression rate was not consistently related to age or gender. By combining disease duration and progression rate, the model predicted that 15% or fewer of the worse eyes would reach the end of the field damage scale in the patient's lifetime. CONCLUSIONS. The estimates of typical worsening per year in the worse eye among subjects with OAG suggested slightly more rapid progression than in some clinic-based studies. The rate did not differ significantly by ethnicity or gender, but was worse in those with known, treated OAG and in pseudophakic subjects.
引用
收藏
页码:66 / 76
页数:11
相关论文
共 58 条
[1]  
Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654
[2]  
BENGTSSON B, 1984, ACTA OPHTHALMOL, V62, P725
[3]   Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies [J].
Bengtsson, B ;
Heijl, A .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 (02) :143-146
[4]   INCIDENCE OF MANIFEST GLAUCOMA [J].
BENGTSSON, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (07) :483-487
[5]   Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study [J].
Borger, PH ;
van Leeuwen, R ;
Hulsman, CAA ;
Wolfs, RCW ;
van der Kuip, DA ;
Hofman, A ;
de Jong, PTVM .
OPHTHALMOLOGY, 2003, 110 (07) :1292-1296
[6]  
Budenz DL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1136
[7]  
Ederer F, 2000, ARCH OPHTHALMOL-CHIC, V118, P1639
[8]   Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years [J].
Eid, TM ;
Spaeth, GL ;
Bitterman, A ;
Steinmann, WC .
OPHTHALMOLOGY, 2003, 110 (05) :900-907
[9]  
Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804
[10]   Medical therapy cost considerations for glaucoma [J].
Fiscella, RG ;
Green, A ;
Patuszynski, DH ;
Wilensky, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (01) :18-25